Combination of an nmda receptor antagonist and a selective...

Details Combination of an nmda receptor antagonist and a selective... Combination of an nmda receptor antagonist and a selective...

A - Human Necessities

61

K

A61K 31/13 (2006.01) A61K 31/16 (2006.01)

Patent

CA 2528622

The present invention provides a method for the treatment of depression, including treatment-resistant depression, and other mood disorders using a combination of an NMDA receptor antagonist and a SSRI that is citalopram or escitalopram. It has unexpectedly been shown that the combination has a synergistic and potentiated effect of either compound as monotherapy, resulting in an enhanced therapeutic effect at lower doses.

L'invention se rapporte à un procédé de traitement de la dépression, y compris la dépression résistant aux traitements, et d'autres troubles de l'humeur au moyen d'une combinaison d'un antagoniste du récepteur NMDA et d'un SSRI qui consiste en citaloprame ou escitaloprame. Il a été prouvé de manière inattendue que cette combinaison possède un effet synergistique et potentialisé de n'importe quel composé en tant que monothérapie, ce qui permet d'obtenir un meilleur effet thérapeutique à des doses inférieures.

Affiliated with

Also associated with

Rating

Combination of an nmda receptor antagonist and a selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of an nmda receptor antagonist and a selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of an nmda receptor antagonist and a selective... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1829597